Association between single nucleotide polymorphisms of the estrogen receptor 1 and receptor activator of nuclear factor kappa B ligand genes and bone mineral density in postmenopausal Taiwanese

• Main Authors: Bi-Hua Cheng, Tzu-Hao Wang, Hong-Yo Kang, Ying-Chu Lin, Chun-Chen Huang, Te-Yao Hsu, Fu-Tsai Kung, Ko-En Huang
• Format: Article
• Language: English
• Published: Elsevier 2013-06-01
• Series: Taiwanese Journal of Obstetrics & Gynecology
• Subjects: bone mineral density; ESR1; single nucleotide polymorphism; RANKL; TNFSF11
• Online Access: http://www.sciencedirect.com/science/article/pii/S1028455913000648
• ISSN: 1028-4559

Objective: To investigate the relationship between single nucleotide polymorphisms (SNPs) of the genes encoding the estrogen receptor 1 (ESR1) and the receptor activator of nuclear factor kappa B ligand (RANKL) and bone mineral density (BMD) in postmenopausal Taiwanese. Materials and Methods: Five ESR1 SNPs and three RANKL SNPs in 467 women were genotyped. Results of genotyping were correlated with BMD that had been adjusted for body mass index (BMI), age, and years after menopause. Results: Those with the ESR1 Crs1884054 allele were found to have a lower BMD at LS2–4/Lateral view (p = 0.005 and permutated p = 0.046), and those with the ESR1 haplotype Trs2234693-Ars922996 had a higher risk for low BMD also at LS2−4/Lat (OR = 1.8, 95% CI = 1.1-2.9). In addition, women without the RANKL haplotype Grs2148072-Crs2200287-Grs922996 had a higher risk for low BMD at LS1−4/AP (OR = 2.09, 95% CI = 1.21 ∼ 3.64). Stratification analyses revealed that those with ESR1 AArs1884054 and RANKL Ars2148072 (p = 0.032) or RANKL Trs2200287 (p = 0.007) had a lower BMD at LS1−4/AP. Conclusion: Genotypes of these SNPs of ESR1 and RANKL may help us predict the osteoporosis risk in menopausal women.